BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31719246)

  • 1. Neurodegenerative diseases as proteinopathies-driven immune disorders.
    Ciccocioppo F; Bologna G; Ercolino E; Pierdomenico L; Simeone P; Lanuti P; Pieragostino D; Del Boccio P; Marchisio M; Miscia S
    Neural Regen Res; 2020 May; 15(5):850-856. PubMed ID: 31719246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential.
    Vuic B; Milos T; Tudor L; Konjevod M; Nikolac Perkovic M; Jazvinscak Jembrek M; Nedic Erjavec G; Svob Strac D
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.
    Kountouras J; Deretzi G; Gavalas E; Zavos C; Polyzos SA; Kazakos E; Giartza-Taxidou E; Vardaka E; Kountouras C; Katsinelos P; Boziki M; Giouleme O
    Med Hypotheses; 2014 Mar; 82(3):368-73. PubMed ID: 24472867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.
    Golde TE; Miller VM
    Alzheimers Res Ther; 2009 Oct; 1(2):5. PubMed ID: 19822029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement cascade functions during brain development and neurodegeneration.
    Fatoba O; Itokazu T; Yamashita T
    FEBS J; 2022 Apr; 289(8):2085-2109. PubMed ID: 33599083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are comorbidities compatible with a molecular pathological classification of neurodegenerative diseases?
    Kovacs GG
    Curr Opin Neurol; 2019 Apr; 32(2):279-291. PubMed ID: 30672825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
    Mosley RL
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):522-7. PubMed ID: 26496777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapies for Neurodegenerative Diseases.
    Mortada I; Farah R; Nabha S; Ojcius DM; Fares Y; Almawi WY; Sadier NS
    Front Neurol; 2021; 12():654739. PubMed ID: 34163421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.
    Kazakos EI; Kountouras J; Polyzos SA; Deretzi G
    Med Hypotheses; 2017 May; 102():33-36. PubMed ID: 28478826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let's make microglia great again in neurodegenerative disorders.
    Guillot-Sestier MV; Town T
    J Neural Transm (Vienna); 2018 May; 125(5):751-770. PubMed ID: 29027011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS inflammation and neurodegeneration.
    Chitnis T; Weiner HL
    J Clin Invest; 2017 Oct; 127(10):3577-3587. PubMed ID: 28872464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.
    Fakhoury M
    Neurodegener Dis; 2015; 15(2):63-9. PubMed ID: 25591815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers.
    Mannini B; Vecchi G; Labrador-Garrido A; Fabre B; Fani G; Franco JM; Lilley K; Pozo D; Vendruscolo M; Chiti F; Dobson CM; Roodveldt C
    ACS Chem Neurosci; 2019 Aug; 10(8):3464-3478. PubMed ID: 31313906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
    Cerami C; Iaccarino L; Perani D
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegenerative diseases: The immunological perspective.
    Molteni M; Rossetti C
    J Neuroimmunol; 2017 Dec; 313():109-115. PubMed ID: 29153601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate and adaptive immunological aspects in neurodegenerative diseases.
    Rodrigues MC; Sanberg PR; Cruz LE; Garbuzova-Davis S
    J Neuroimmunol; 2014 Apr; 269(1-2):1-8. PubMed ID: 24161471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.
    Visanji NP; Lang AE; Kovacs GG
    Transl Neurodegener; 2019; 8():28. PubMed ID: 31508228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of T Cell Immunity in Atopic Dermatitis by Microbes: The Yin and Yang of Cutaneous Inflammation.
    Biedermann T; Skabytska Y; Kaesler S; Volz T
    Front Immunol; 2015; 6():353. PubMed ID: 26217343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.